Metabolism of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Inhibitor Delavirdine in Rats

PDF] Metabolism of the human immunodeficiency virus type 1 reverse transcriptase inhibitor delavirdine in rats.

Frontiers Human immunodeficiency virus and antiretroviral therapy-mediated immune cell metabolic dysregulation in children born to HIV-infected women: potential clinical implications

Structure and Function of HIV-1 Reverse Transcriptase: Molecular Mechanisms of Polymerization and Inhibition - ScienceDirect

IJMS, Free Full-Text

Full article: Current and emerging non-nucleoside reverse transcriptase inhibitors (NNRTIs) for HIV-1 treatment

Full article: Anti-HIV potential of diarylpyrimidine derivatives as non-nucleoside reverse transcriptase inhibitors: design, synthesis, docking, TOPKAT analysis and molecular dynamics simulations

Metabolism of Delavirdine, a Human Immunodeficiency Virus Type-1 Reverse Transcriptase Inhibitor, by Microsomal Cytochrome P450 in Humans, Rats, and Other Species: Probable Involvement of CYP2D6 and CYP3A

Main metabolic routes of nevirapine.

Human Immunodeficiency Virus Reverse Transcriptase: 25 Years of Research, Drug Discovery, and Promise* - Journal of Biological Chemistry

Current insights and molecular docking studies of HIV‐1 reverse transcriptase inhibitors - Singh - 2024 - Chemical Biology & Drug Design - Wiley Online Library

Chemical structures of inhibitors of HIV-1 RT. (A)

Looking for an Active Conformation of the Future HIV Type-1 Non-Nucleoside Reverse Transcriptase Inhibitors - Giuseppe La Regina, Antonio Coluccia, Romano Silvestri, 2010

HIV-1 inhibitor MedChemExpress (MCE) Life Science Reagents

The Promise of Long-Acting Antiretroviral Therapies: From Need to Manufacture: Trends in Microbiology

Metabolism of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Inhibitor Delavirdine in Rats